obezitatea într-o comunitate rurală din judeţul iaşi - Gr.T. Popa

International Diabetes Federation definitions. Curr Med Res Opin 2005; 21: 1157-
1159.
166. Ford ES. Prevalence of the metabolic syndrome defined by the International
Diabetes Federation among adults in US. Diabetes Care 2005; 28: 2745-2749.
167. Gomila S, Dallongeville J. Epidemiologie du syndrome metabolique en France.
Med Nutr 2003;39:89-94.
168. Hu G, Qiao Q, Tuomilehti J et al. Prevalence of metabolic syndrome and its
relation to all cause mortality in nondiabetic European men and women. Arch
Intern Med 2004;164:1066-1076.
169. Ravaglia G, Forti P, Maioli F et al. Metabolic syndrome. Prevalence and
prediction of mortality in elderly individuals. Diabetes Care 2006; 29(11): 2471-
2476.
170. Lau DCW, Yan H, Dhillon B. Metabolic syndrome: a marker of patients at high
cardiovascular risk. Can J Cardiol 2006;22(suppl B):85B-90B.
171. Sironi AM, Gastadelli A, Mari A et al. Visceral fat in Hypertension. Influence on
insulin resistance and beta-cell function. Hypertension 2004;44:127-133.
172. Balkau B, Picard P, Vol S et al. Consequences of change in waist circumference
on cardiometabolic risk factors over 9 years. Diabetes Care 2007;30:1901-1903.
173. Vega GL, Adams-Huet B, Peshock R et al. Influence of body fat content and
distribution on variation in metabolic risk. J Clin Endocrinol Metab 2006; 91:
4459-4466.
174. Zhu S, Wang Z, Heshka S et al. Waist circumference and obesity-associated risk
factors among whites in the third National Health and Nutrition Examination
Survey: clinical action thresholds. Am J Clin Nutr 2001;76:743-749.
175. Janiszewski PM, Janssen I, Ross R. Does waist circumference predict diabetes and
cardiovascular disease beyond commonly evaluated cardiometabolic risk factors?
Diabetes Care 2007;30:3105-3109.
176. Isomaa B, Almgren P, Tuomi T, et al. Cardiovascular morbidity and mortality
associated with the metabolic syndrome. Diabetes Care 2001;24(4):683-689.
177. Lemieux S. Contribution of visceral obesity to the insulin resistance syndrome.
Can J Appl Physiol 2001;26:273-290.
178. Ross R, Fortier L, Hudson R. Separate associations between visceral and
subcutaneous adipose tissue distribution, insulin and glucose levels in obese
women. Diabetes Care 1996;19:1404-1411.
179. Despres JP, Nadeau A, Tremblay A et al. Role of deep abdominal fat in the
association between regional adipose tissue distribution and glucose tolerance in
obese women. Diabetes 1989;38:304-309.
180. Despres JP, Arsenault B, Cote m et al. Abdominal obesity: the cholesterol of the
21th century? Can J Cardiol 2008;24(suppl D):7D-12D.
181. Conus F, Rabasa.Lhoret R, Peronnet F. Characteristics of metabolically obese
normal-weight (MONW) subjects. Appl Physiol Nutr Metab 2007;32:4-12.
182. Grundy SM. Metabolic syndrome: connecting and reconcilling cardiovascular and
diabetes worlds. J Am Coll Cardiol 2006;47:1093-1100.
183. Park YW, Zhu S, Palaniappan L et al. The metabolic syndrome: prevalence and
associated risk factor findings in the US population from the Third National
Health and Nutrition Examination Survey, 1988-1994. Arch Inter Med
2003;163:427-436.
47